BioCentury
ARTICLE | Clinical News

Exparel: Completed Phase III enrollment

January 12, 2009 8:00 AM UTC

Pacira completed enrollment of >200 patients undergoing bone surgical procedures in the double-blind, active-controlled, U.S. Phase III SIMPLE trial to evaluate a single dose of injectable Exparel. ...